What is PCOS and why does renaming it to PMOS matter?, Pg13

Key Highlights:

• Polycystic Ovary Syndrome (PCOS), a common hormonal condition in women, is being renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS).
• The name change reflects the condition's broader impact beyond the ovaries, encompassing metabolic, hormonal, reproductive, and psychological aspects.
• PMOS includes metabolic features like obesity, abnormal blood sugar, and cardiovascular risks, reproductive issues like infertility, psychological issues like depression, and dermatological issues like acne.
• The prevalence of PCOS/PMOS in India is estimated to be between 16% and 18%.
• The new name aims to promote a more comprehensive and multidisciplinary approach to diagnosis and management.

Detailed Insights:

• The traditional term PCOS focused narrowly on ovarian cysts, which are often a misconception arising from immature follicles appearing on ultrasound scans.
• PMOS emphasizes the need for screening for blood sugar, cholesterol, and blood pressure to address long-term health risks.
• The renaming is expected to improve awareness among both patients and healthcare providers, leading to earlier recognition of symptoms.
• In India, the change could encourage earlier screening for obesity, diabetes, and hypertension, given the genetic predisposition of Indians to these conditions.
• While the new name won't immediately change diagnostic criteria or treatment protocols, it promotes a more holistic approach to patient care.
• Delayed diagnosis of PCOS/PMOS in India can lead to unmanaged symptoms and missed opportunities to prevent complications like insulin resistance and cardiovascular risks.
• The global rollout of the new name, PMOS, is expected to occur over the next three years.

Key Concepts Involved:

• Androgens: Hormones that regulate masculine characteristics; their excess production is associated with PCOS/PMOS.
• Dysglycaemia: Abnormal blood sugar level, a metabolic feature of PMOS.
• Insulin Resistance: A condition in which cells do not respond normally to insulin, increasing the risk of type 2 diabetes.